STRO vs TRMB
Sutro Biopharma (STRO) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TRMB revenue for 2025-01-03 was $3.68B. Net income was $1.50B. Revenue was down 3.0% from 2023-12-29 to 2025-01-03. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
STRO currently screens at market cap $470.8M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the STRO and TRMB stock pages for the full models.
Not investment advice.